Making Cancer Care More Cost-Effective

Alex A. Adjei, MD, PhD, FACP

Video Categories: Value

Dr. Alex Adjei offers options to make cancer care more cost-effective, such as selecting only patients who will benefit from treatment and continuing to offer treatments that will allow patients to remain in the workforce.
March 31, 2015

The Molecular Biology of Myeloma

Dr. David S. Siegel discusses the importance of understanding the molecular biology of myeloma. Physicians can now look at and offer alternative treatments to patients that they identify will most likely do poorly with traditional treatment. He believes this area will develop quickly over the next 2 to 5 years.

July 13, 2021
IWTI-Cohen-Fidler-LoaizaBonilla-01-A-Still

Who Should Be Screened for Tumor Mutations?

Dr Ezra Cohen of UC San Diego, La Jolla, CA; Dr Mary Fidler of Rush University Medical Center, Chicago, IL; and Dr Arturo Loaiza-Bonilla of the Comprehensive Care and Research Center, Philadelphia, PA, examine who should be tested for tumor mutations.